New drug combo tested to better control blood sugar
NCT ID NCT02354235
Summary
This study tested whether adding the drug canagliflozin to an existing medication (teneligliptin) could help Japanese adults with type 2 diabetes who still had high blood sugar. For 24 weeks, researchers measured changes in long-term blood sugar levels (HbA1c), body weight, and other health markers. The goal was to see if this combination was safe and more effective at managing diabetes than the single drug alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Reserch site
Kanto, Japan
-
Reserch site
Kinki, Japan
-
Reserch site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.